New scientific research shows that a medical marijuana compound may be able to increase the probability of surviving pancreatic cancer.
In a study published in the journal Oncogene, experts found that mice with pancreatic cancer survived nearly three times longer when treated with a combination of cannabidiol (CBD) and chemotherapy, compared to mice treated only with chemotherapy.
The study’s main author, Professor Marco Falasca, led a research team from Queen Mary University of London (QMUL) in the United Kingdom, and Curtin University in Bentley and Perth, Australia. They found that administering CBD — a naturally occurring component found in medical cannabis — alongside chemotherapy medication improved the prognosis of mice with pancreatic cancer.
“This is a remarkable result,” said Prof. Falasca. “We found that mice with pancreatic cancer survived nearly three times longer if a constituent of medicinal cannabis was added to their chemotherapy treatment.”
Pancreatic cancer is one of the most deadliest types of cancer, with a mere 8.5 percent survival rate within 5 years of diagnosis, according to the National…